Physician

Christopher Charles Copenhaver, M.D,

According to 2025 Medicare claims, Christopher Copenhaver, M.D, (NPI: 1659370708) practices allergy/immunology in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is ALLERGY PARTNERS, PLLC (NPI: 1205826559; TIN: 561249571) and primary practice location at 28801-4104. Copenhaver is affiliated with the Mission Health Partners, LLC (ACO ID: A2591) and CVS ACO (ACO ID: A5407), participating under the MSSP model.

Copenhaver's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 990 traditional Medicare patients, billed 31,162 HCPCS/CPT codes, and received $426,320 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,969 prescription claims across 421 beneficiaries totaling $486,323 in drug costs, led by Dupixent Pen (Dupilumab). DME data shows 412 claims. Open Payments data shows 101 records totaling $20,192. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $191,316 to $426,320. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $127,641 to $486,323. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $2,927 to $10,420.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$226K$453K2015 Medicare payment: $191,316 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $224,139 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $255,830 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $263,166 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $384,417 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $445,239 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $410,992 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $452,591 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $418,275 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $426,320 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,21421,215$191,316
20161,36324,425$224,139
20171,35424,993$255,830
20181,36125,888$263,166
20191,35731,100$384,417
20201,24031,621$445,239
20211,07427,197$410,992
20221,08029,049$452,591
20231,01727,693$418,275
202499031,162$426,320

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$261K$522K2015 Drug cost: $127,641 (USD; Tot_Drug_Cst)2016 Drug cost: $155,439 (USD; Tot_Drug_Cst)2017 Drug cost: $213,012 (USD; Tot_Drug_Cst)2018 Drug cost: $218,805 (USD; Tot_Drug_Cst)2019 Drug cost: $319,451 (USD; Tot_Drug_Cst)2020 Drug cost: $443,083 (USD; Tot_Drug_Cst)2021 Drug cost: $522,395 (USD; Tot_Drug_Cst)2022 Drug cost: $432,706 (USD; Tot_Drug_Cst)2023 Drug cost: $461,439 (USD; Tot_Drug_Cst)2024 Drug cost: $486,323 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153471,481$127,641
20163881,839$155,439
20173891,979$213,012
20184271,962$218,805
20194562,068$319,451
20204872,313$443,083
20214502,214$522,395
20224282,033$432,706
20234251,848$461,439
20244211,969$486,323

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$369K$739K2015 Medicare payment: $69,838 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $75,971 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $85,748 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $115,274 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $287,425 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $474,105 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $571,490 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $738,617 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $570,054 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $577,173 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R134$69,838
2016N/R165$75,971
2017N/R116$85,748
2018N/R204$115,274
2019N/R425$287,425
2020N/R501$474,105
202122480$571,490
202224535$738,617
202324400$570,054
2024N/R412$577,173

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more201247$83
95165Professional service for preparation and provision of 1 or more antigens3287,620$10
95117Professional service for multiple injections of allergen5432,464$8
95115Professional service for single injection of allergen207956$6
96160Administration and interpretation of patient-focused health risk assessment226245$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab17756$101,939
Trelegy ElliptaFluticasone/Umeclidin/Vilanter783,360$71,236
SymbicortBudesonide/Formoterol Fumarate873,939$28,363
Breo ElliptaFluticasone/Vilanterol421,920$23,248
Ipratropium BromideIpratropium Bromide22610,390$14,498

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1559Injection, immune globulin (hizentra), 100 mgNN/R97$426,539
J1558Injection, immune globulin (xembify), 100 mgNN/R13$86,989
J1569Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mgNN/R11$50,330
A4221Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)NN/R110$6,893
J7606Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 microgramsNN/R18$2,482

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.101$20,192AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Christopher Charles Copenhaver, M.D, ?

Tedicare shows public-source Medicare data for Christopher Charles Copenhaver, M.D, (NPI 1659370708), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Charles Copenhaver, M.D, have ACO affiliation data?

Christopher Charles Copenhaver, M.D, is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591) and CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Christopher Charles Copenhaver, M.D, ?

Christopher Charles Copenhaver, M.D, is linked to ALLERGY PARTNERS, PLLC (billing NPI 1205826559) in the available physician profile data.

Does Christopher Charles Copenhaver, M.D, have Open Payments data?

Christopher Charles Copenhaver, M.D, has 101 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.